Analyst Ratings for Relay Therapeutics (RLAY) [Buys]
RLAY Rating Summary
RLAY Price Target Summary
- Highest: $32.00 (BofA Securities)
- Lowest: $10.60 (Jefferies)
- Average: $23.23
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$23.23 (+295%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/19/2023 | Raymond James | Dane Leone | Upgrade | Strong Buy (Outperform) |
29.00 (N/A) |
11.62 (5.88) |
-49.4% | Details |
| 2/3/2023 | Oppenheimer » Updated 4/5/2023 |
Matt Biegler | New Coverage | Outperform (N/A) |
33.00 (N/A) |
21.68 (5.88) |
-72.88% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
